We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

CO-Oximetry External QA Programme Launched

By LabMedica International staff writers
Posted on 22 Mar 2018
Print article
Image: The CO-Oximetry External Quality Assessment Programme can be used with the ABL80 FLEX CO-OX blood gas analyzer (Photo courtesy of Randox).
Image: The CO-Oximetry External Quality Assessment Programme can be used with the ABL80 FLEX CO-OX blood gas analyzer (Photo courtesy of Randox).
Co-oximetry is a methodology that measures the levels of the oxygen-carrying protein haemoglobin, which is the chief component of red blood cells and CO-oximetry is useful in defining the causes for hypoxemia, or hypoxia.

Co-oximetry is a useful tool in that it helps determine the levels of various forms of haemoglobin and can be used to diagnose a variety of conditions related to oxygen content in blood. Oxygen content is an important indicator of oxygen transport within the body. The oxygen transport of arterial blood is used to evaluate the ability of transporting oxygen from the lungs to the tissue.

A new CO-Oximetry programme to complement their existing Blood Gas programme has been launched by Randox (Crumlin, UK). The programme combines seven parameters in a user-friendly, liquid ready-to-use format, the new RIQAS CO-Oximetry External Quality Assessment (EQA) programme has been designed with consolidation and convenience in mind and it is even suitable for use in point-of-care testing. All samples are supplied in a liquid ready-to-use format ideal for both clinical and point-of-care testing.

The seven parameters covered by the programme are: Carboxyhaemoglobin (COHb / HbCO); Methaemoglobin (MetHb); Oxygen Content (O₂CT); Oxygen Saturation (sO₂ / Vol O₂); Oxyhaemoglobin (O₂Hb / HbO₂); Total Haemoglobin (tHb); and Reduced / Deoxyhaemoglobin (RHb / HHb). A high value for the Co-Oximetry Blood Test may indicate, among other things: carbon monoxide poisoning or congenital haemoglobin disorder. To compliment the RIQAS CO-Oximetry EQA Programme, the RIQAS Blood Gas EQA programme incorporates 10 parameters into a liquid ready-to-use format for ease of use.

RIQAS is the world’s largest EQA scheme with 45,000 participants and 33 programmes ensuring peer groups are maximised. Lynsey Adams, BSc, the Quality Control Marketing Manager at Randox, said, “The launch of our new CO-Oximetry programme means we now offer a complete EQA solution for blood gas testing.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.